|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61P 1/04 | (2006.01) | ||
| A61P 17/00 | (2006.01) |
| (11) | Patento numeris | 3524230 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18213458.5 |
| Europos patento paraiškos padavimo data | 2013-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 12163078 | 2012-04-04 | EP |
| (72) |
FETSCHER, Alfred , DE
SCHER, Jochen Matthias , DE
|
| (73) |
Alkahest, Inc. ,
125 Shoreway Road, Suite D, San Carlos, CA 94070,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS |
| PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS |